Search research articles
Contact Us
Filters
Showing results (21-30 of 34) with videos related to
Page
of 4
Sort By:
Cancer
|
June 14, 2005
Serum HER-2/neu conversion to positive at the time of disease progression in patients with breast carcinoma on hormone therapy
Allan Lipton, Kim Leitzel, Suhail M Ali, et al.
Cells
|
March 6, 2021
Cellular Fitness Phenotypes of Cancer Target Genes from Oncobiology to Cancer Therapeutics
Bijesh George, P Mukundan Pillai, Aswathy Mary Paul, et al.
Cancer
|
September 24, 2010
Elevated plasma tissue inhibitor of metalloproteinase-1 levels predict decreased survival in castration-resistant prostate cancer patients
William K Oh, Roberto Vargas, Susanna Jacobus, et al.
International Journal of Cancer
|
June 21, 2018
High turnover of extracellular matrix reflected by specific protein fragments measured in serum is associated with poor outcomes in two metastatic breast cancer cohorts
Allan Lipton, Kim Leitzel, Suhail M Ali, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 29, 2010
Quantitation of p95HER2 in paraffin sections by using a p95-specific antibody and correlation with outcome in a cohort of trastuzumab-treated breast cancer patients
Jeff Sperinde, Xueguang Jin, Jayee Banerjee, et al.
Cancer
|
May 3, 2017
Osteoporosis therapy and outcomes for postmenopausal patients with hormone receptor-positive breast cancer: NCIC CTG MA.27
Allan Lipton, Judith-Anne W Chapman, Kim Leitzel, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
September 12, 2009
Safety, pharmacokinetics, and pharmacodynamics of the insulin-like growth factor type 1 receptor inhibitor figitumumab (CP-751,871) in combination with paclitaxel and carboplatin
Daniel D Karp, Michael N Pollak, Roger B Cohen, et al.
Scientific Reports
|
December 26, 2019
Collagen fragments quantified in serum as measures of desmoplasia associate with survival outcome in patients with advanced pancreatic cancer
Nicholas Willumsen, Suhail M Ali, Kim Leitzel, et al.
Breast Cancer Research and Treatment
|
May 10, 2017
Impact of serum HER2, TIMP-1, and CAIX on outcome for HER2+ metastatic breast cancer patients: CCTG MA.31 (lapatinib vs. trastuzumab)
Diep Ho, Jessica Huang, Judith-Anne W Chapman, et al.
Calcified Tissue International
|
June 20, 2018
The C-Terminal Intact Forms of Periostin (iPTN) Are Surrogate Markers for Osteolytic Lesions in Experimental Breast Cancer Bone Metastasis
Evelyne Gineyts, Nicolas Bonnet, Cindy Bertholon, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 34) with videos related to
Sort By:
Page
of 4
Cancer
|
June 14, 2005
Serum HER-2/neu conversion to positive at the time of disease progression in patients with breast carcinoma on hormone therapy
Allan Lipton, Kim Leitzel, Suhail M Ali, et al.
Cells
|
March 6, 2021
Cellular Fitness Phenotypes of Cancer Target Genes from Oncobiology to Cancer Therapeutics
Bijesh George, P Mukundan Pillai, Aswathy Mary Paul, et al.
Cancer
|
September 24, 2010
Elevated plasma tissue inhibitor of metalloproteinase-1 levels predict decreased survival in castration-resistant prostate cancer patients
William K Oh, Roberto Vargas, Susanna Jacobus, et al.
International Journal of Cancer
|
June 21, 2018
High turnover of extracellular matrix reflected by specific protein fragments measured in serum is associated with poor outcomes in two metastatic breast cancer cohorts
Allan Lipton, Kim Leitzel, Suhail M Ali, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 29, 2010
Quantitation of p95HER2 in paraffin sections by using a p95-specific antibody and correlation with outcome in a cohort of trastuzumab-treated breast cancer patients
Jeff Sperinde, Xueguang Jin, Jayee Banerjee, et al.
Cancer
|
May 3, 2017
Osteoporosis therapy and outcomes for postmenopausal patients with hormone receptor-positive breast cancer: NCIC CTG MA.27
Allan Lipton, Judith-Anne W Chapman, Kim Leitzel, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
September 12, 2009
Safety, pharmacokinetics, and pharmacodynamics of the insulin-like growth factor type 1 receptor inhibitor figitumumab (CP-751,871) in combination with paclitaxel and carboplatin
Daniel D Karp, Michael N Pollak, Roger B Cohen, et al.
Scientific Reports
|
December 26, 2019
Collagen fragments quantified in serum as measures of desmoplasia associate with survival outcome in patients with advanced pancreatic cancer
Nicholas Willumsen, Suhail M Ali, Kim Leitzel, et al.
Breast Cancer Research and Treatment
|
May 10, 2017
Impact of serum HER2, TIMP-1, and CAIX on outcome for HER2+ metastatic breast cancer patients: CCTG MA.31 (lapatinib vs. trastuzumab)
Diep Ho, Jessica Huang, Judith-Anne W Chapman, et al.
Calcified Tissue International
|
June 20, 2018
The C-Terminal Intact Forms of Periostin (iPTN) Are Surrogate Markers for Osteolytic Lesions in Experimental Breast Cancer Bone Metastasis
Evelyne Gineyts, Nicolas Bonnet, Cindy Bertholon, et al.
Page
of 4